Paradigm Asset Management’s Gilead Sciences GILD Stock Holding History

Paradigm Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$125K	Hold	900	–	–	0.03%	309
2025 Q4	$110K	Hold	900	–	–	0.03%	331
2025 Q3	$99.9K	Hold	900	–	–	0.02%	331
2025 Q2	$99.8K	Sell	900 -9,700	-92%	-$1.03M	0.02%	325
2025 Q1	$1.19M	Hold	10,600	–	–	0.32%	130
2024 Q4	$979K	Sell	10,600 -8,100	-43%	-$729K	0.27%	163
2024 Q3	$1.57M	Hold	18,700	–	–	0.41%	84
2024 Q2	$1.28M	Sell	18,700 -4,750	-20%	-$317K	0.36%	104
2024 Q1	$1.72M	Sell	23,450 -550	-2%	-$42.3K	0.44%	64
2023 Q4	$1.94M	Sell	24,000 -700	-3%	-$54.5K	0.51%	42
2023 Q3	$1.85M	Sell	24,700 -1,300	-5%	-$100K	0.52%	41
2023 Q2	$2M	Buy	26,000 +21,700	+505%	+$1.73M	0.54%	40
2023 Q1	$357K	Hold	4,300	–	–	0.1%	243
2022 Q4	$369K	Buy	+4,300	New	+$341K	0.1%	252
2022 Q2	–	Sell	-4,500	Closed	-$268K	–	426
2022 Q1	$268K	Hold	4,500	–	–	0.07%	273
2021 Q4	$327K	Sell	4,500 -600	-12%	-$41.3K	0.08%	265
2021 Q3	$356K	Sell	5,100 -600	-11%	-$42.2K	0.1%	267
2021 Q2	$393K	Sell	5,700 -400	-7%	-$26.7K	0.1%	276
2021 Q1	$394K	Sell	6,100 -600	-9%	-$38.7K	0.11%	277
2020 Q4	$390K	Sell	6,700 -8,610	-56%	-$520K	0.11%	274
2020 Q3	$967K	Sell	15,310 -2,500	-14%	-$173K	0.3%	118
2020 Q2	$1.37M	Sell	17,810 -3,800	-18%	-$291K	0.42%	58
2020 Q1	$1.62M	Buy	21,610 +5,900	+38%	+$408K	0.63%	27
2019 Q4	$1.02M	Buy	15,710 +700	+5%	+$45.6K	0.3%	158
2019 Q3	$951K	Sell	15,010 -3,200	-18%	-$209K	0.31%	146
2019 Q2	$1.23M	Sell	18,210 -1,150	-6%	-$75.7K	0.35%	103
2019 Q1	$1.26M	Sell	19,360 -1,000	-5%	-$66.5K	0.37%	95
2018 Q4	$1.27M	Sell	20,360 -24,700	-55%	-$1.73M	0.41%	78
2018 Q3	$3.48M	Buy	45,060 +4,250	+10%	+$321K	0.97%	11
2018 Q2	$2.89M	Hold	40,810	–	–	0.84%	17
2018 Q1	$3.08M	Sell	40,810 -2,600	-6%	-$207K	0.89%	11
2017 Q4	$3.11M	Buy	43,410 +6,700	+18%	+$509K	0.85%	13
2017 Q3	$2.97M	Sell	36,710 -12,950	-26%	-$990K	0.77%	43
2017 Q2	$3.51M	Buy	49,660 +30,000	+153%	+$2M	0.71%	56
2017 Q1	$1.34M	Sell	19,660 -3,990	-17%	-$281K	0.25%	96
2016 Q4	$1.69M	Buy	+23,650	New	+$1.76M	0.33%	88
2016 Q3	–	Sell	-7,822	Closed	-$653K	–	695
2016 Q2	$653K	Sell	7,822 -34,278	-81%	-$3.04M	0.11%	180
2016 Q1	$3.87M	Buy	42,100 +4,600	+12%	+$415K	0.72%	66
2015 Q4	$3.79M	Buy	37,500 +26,700	+247%	+$2.78M	0.65%	67
2015 Q3	$1.06M	Buy	10,800 +2,300	+27%	+$255K	0.14%	177
2015 Q2	$995K	Buy	8,500 +100	+1%	+$10.9K	0.11%	203
2015 Q1	$824K	Buy	+8,400	New	+$853K	0.09%	241
2014 Q2	–	Sell	-11,000	Closed	-$779K	–	807
2014 Q1	$779K	Hold	11,000	–	–	0.11%	211
2013 Q4	$827K	Buy	+11,000	New	+$766K	0.13%	210

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Paradigm Asset Management's GILD Position: Q1 2026 in Review

Paradigm Asset Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 900 shares worth $125K. The position accounts for 0.03% of the portfolio, ranked #309.

Paradigm Asset Management first reported a position in GILD in Q4 2013 and has held it in 44 quarters since. The position peaked at $3.87M in Q1 2016. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Paradigm Asset Management held 900 shares of Gilead Sciences worth $125K as of Q1 2026.
Paradigm Asset Management left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.03% of Paradigm Asset Management's portfolio in Q1 2026, its #309 holding.
Paradigm Asset Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 44 quarters since.
Paradigm Asset Management's Gilead Sciences position peaked at $3.87M in Q1 2016.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Paradigm Asset Management's 13F filing for Q1 2026, filed 12 May 2026.